Cargando…
ACT-17 Protocol design of a matrix-type of novel clinical trial for lower-grade gliomas
Introduction: Differentiation between glioma grade 2 and 3 was performed based on histological findings. The current grade is an important prognostic factor due to its widespread use, economic efficiency, and data accumulation, but analog elements remain and the genetic marker is unknown. The concep...
Autores principales: | Muragaki, Yoshihiro, Nitta, Masayuki, Saito, Taiichi, Tsuzuki, Shunsuke, Fukui, Atsushi, Ikuta, Soko, Maruyama, Takashi, Komori, Takashi, Kawamata, Takakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699113/ http://dx.doi.org/10.1093/noajnl/vdaa143.036 |
Ejemplares similares
-
ACT-05 PREDICTIVE FACTORS RELATING TO OUTCOME AFTER RESECTION OF LOW-GRADE GLIOMAS WITHOUT CHEMOTHERAPY OR RADIOTHERAPY
por: Ikuta, Soko, et al.
Publicado: (2019) -
ACT-22 CLINICAL RESULT AND CONSIDERATION OF 70 CASES OF INSULAR GLIOMA
por: Maruyama, Takashi, et al.
Publicado: (2019) -
IMT-05 PHASE III RANDOMIZED CLINICAL TRIAL OF AFTV FOR NEWLY DIAGNOSED GLIOBLASTOMA
por: Nitta, Masayuki, et al.
Publicado: (2019) -
STMO-08 INFLUENCE OF WIDE OPENING OF THE LATERAL VENTRICLE ON SURVIVAL FOR SUPRATENTORIAL GLIOBLASTOMA PATIENTS WITH RADIOTHERAPY AND CONCOMITANT TEMOZOLOMIDE-BASED CHEMOTHERAPY
por: Saito, Taiichi, et al.
Publicado: (2019) -
MPC-17 USEFULNESS OF INTRAOPERATIVE MOLECULAR DIAGNOSIS OF GLIOMA USING REAL-TIME PCR
por: Koriyama, Shunichi, et al.
Publicado: (2019)